Acute liver failure caused by lymphocyte-depleted Hodgkin lymphoma in tuberculosis and HIV-infected patient
Mayur Parkhi; Madhumita Premkumar; Amanjit Bal; Ashim Das; Sanjay Jain; Suvradeep Mitra
Abstract
Keywords
References
1 Major A, Jackson MW, Smith DE, Kamdar M, Rabinovitch R. Inferior outcomes and treatment disparities in elderly patients with classical Hodgkin lymphoma: a national cancer database analysis. Leuk Lymphoma. 2019;60(5):1234-43.
2 Eberle FC, Mani H, Jaffe ES. Histopathology of Hodgkin’s lymphoma. Cancer J. 2009;15(2):129-37.
3 Karube K, Niino D, Kimura Y, Ohshima K. Classical Hodgkin lymphoma, lymphocyte depleted type: clinicopathological analysis and prognostic comparison with other types of classical Hodgkin lymphoma. Pathol Res Pract. 2013;209(4):201-7.
4 Mauch PM, Kalish LA, Kadin M, Coleman CN, Osteen R, Hellman S. Patterns of presentation of Hodgkin disease. Implications for aetiology and pathogenesis. Cancer. 1993;71(6):2062-71.
5 Shiels MS, Koritzinsky EH, Clarke CA, Suneja G, Morton LM, Engels EA. Prevalence of HIV Infection among U.S. Hodgkin lymphoma cases. Cancer Epidemiol Biomarkers Prev. 2014;23(2):274-81.
6 Schwering I, Bräuninger A, Klein U, et al. Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood. 2003;101(4):1505-12.
7 Borges AM, Delabie J, Vielh P, et al. Classic Hodgkin Lymphoma. In: WHO Classification of Tumours Editorial Board. Haematolymphoid tumours. Lyon: International Agency for Research on Cancer; 2022.
8 Green MR, Rodig S, Juszczynski P, et al. Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy. Clin Cancer Res. 2012;18(6):1611-8.
9 Imbeault M, Ouellet M, Giguère K, et al. Acquisition of host-derived CD40L by HIV-1 in vivo and its functional consequences in the B-cell compartment. J Virol. 2011;85(5):2189-200.
10 Trewby PN, Portmann B, Brinkley DM, Williams R. Liver disease as presenting manifestation of Hodgkin’s disease. Q J Med. 1979;48(189):137-50. PMid:482587.
11 Karmacharya P, Bhandari N, Aryal MR, et al. Before it crumbles: fulminant hepatic failure secondary to Hodgkin’s Lymphoma. J Community Hosp Intern Med Perspect. 2014;4(5):25821.
12 Murakami J, Shimizu Y. Hepatic manifestations in hematological disorders. Int J Hepatol. 2013;2013:484903.
13 Mihăilă RG. Liver Involvement in Hodgkin’s Lymphoma: types of injuries and therapeutic implications. Int J Pharmacol Phytochem Ethnomed. 2017;8:1-15.
14 Reddy RC, Mathew M, Parameswaran A, Narasimhan R. A case of concomitant Hodgkin’s lymphoma with tuberculosis. Lung India. 2014;31(1):59-62.
15 Kaplan MH, Armstrong D, Rosen P. Tuberculosis complicating neoplastic disease. A review of 201 cases. Cancer. 1974;33(3):850-8.
16 Banerjee A, Bhuller K, Sudhir R, Bajaj A. Diagnostic dilemma of Hodgkin’s lymphoma versus tuberculosis: a case report and review of the literature. J Med Case Rep. 2021;15(1):351.
17 El Bouhmadi K, Oukessou Y, Rouadi S, Abada R, Roubal M, Mahtar M. Association of multifocal Hodgkin’s lymphoma and tuberculosis infection: a challenging entity. Int J Surg Case Rep. 2022;90:106711.
18 Mustafa Ali M, Ruano Mendez AL, Carraway HE. Hemophagocytic Lymphohistiocytosis in a patient with hodgkin lymphoma and concurrent EBV, CMV, and candida infections. J Investig Med High Impact Case Rep. 2017;5(1):2324709616684514.
19 Tabaja H, Kanj A, El Zein S, Comba IY, Chehab O, Mahmood M. A review of hemophagocytic lymphohistiocytosis in patients with HIV. Open Forum Infect Dis. 2022 Feb 11;9(4):ofac071.
Submitted date:
01/07/2024
Accepted date:
04/04/2024
Publication date:
05/22/2024